Black fungi: clinical and pathogenic approaches

References

• Haase G, Sonntag L, Melzer-Krick B, De Hoog GS. Phyloge-netic inference by SSU-gene analysis of members of the Her-potrichiellaceae with special reference to human pathogenic species. Stud Mycol 1999; 43: 80–97.
   Google Scholar
• Schnitzler N, Peltroche-Llacsahuanga H, Bestier N, Ziindorf J, Liitticken J, Haase G. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils. Infect Immun 1999; 67: 94–101.
   PubMed Web of Science ®Google Scholar
• Fader RC, McGinnis MR. Infections caused by dematiaceous fungi: Chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North Am 1988; 2: 925–938.
   PubMedGoogle Scholar
• Butler MJ, Day AW. Fungal melanins: a review. Can J M icro-biol 1998; 44: 1115–1136.
   Web of Science ®Google Scholar
• Money NP, Howard RJ. Confirmation of a link between fungal pigmentation, turgor pressure, and pathogenicity using a new method of turgor measurement. Fungal Genet Biol 1996; 20: 217–227.
   Web of Science ®Google Scholar
• Wheeler MH, Bell AA. Melanins and their importance in pathogenic fungi. Curr Top Med Mycol 1988; 2: 338–387.
   PubMedGoogle Scholar
• Listemann H, Freiesleben H. Exophiala mesophila spec. nov. Mycoses 1996; 39: 1–3.
   PubMed Web of Science ®Google Scholar
• Brush L, Money NP. Invasive hyphal growth in Wangiella dermatitidis is induced by stab inoculation and shows depen-dence upon melanin biosynthesis. Fungal Gen Biol 1999; 28: 190–200.
   PubMed Web of Science ®Google Scholar
• Ye X, Feng B, Szaniszlo PJ. A color-selectable and site-specific integrative transformation system for gene expression studies in the dematiaceous fungus Wangiella (Exophiala) dermatitidis. Curr Genet 1999; 36: 241–247.
   Google Scholar
• Gerrits van den Ende AHG, De Hoog GS. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud Mycol 1999; 43: 151–162.
   Google Scholar
• Untereiner WA. Fruiting studies in species of Capronia (Her-potrichiellaceae). Ant van Leeuwenhoek 1995; 68: 3–17.
   PubMed Web of Science ®Google Scholar
• Untereiner WA. Taxonomy of selected members of the as-comycete genus Capronia with notes on anamorph-teleomorph connections. Mycologia 1997; 89: 120–131.
   Web of Science ®Google Scholar
• Untereiner WA, Straus NA, Malloch D. A molecular-morpho-taxonomic approach to the systematics of the Herpotrichiel-laceae and allied black yeasts. Mycol Res 1995; 99: 897–913.
   Google Scholar
• Untereiner WA, Naveau F. Molecular systematics of the Her-potrichiellaceae with an assessment of the phylogenetic posi-tions of Exophiala dermatitidis and Phialophora americana. Mycologia 1999; 91: 67–83.
   Web of Science ®Google Scholar
• De Hoog GS, Poonwan N, Gerrits van den Ende AHG. Taxonomy of Exophiala spinifera and its relationship to E. jeanselmei. Stud Mycol 1999; 43: 133–142.
   Google Scholar
• Haase G, Sonntag L, Melzer-Krick B, De Hoog GS. Phyloge-netic inference by SSU-gene analysis of members of the Her-potrichiellaceae with special reference to human pathogenic species. Stud Mycol 1999; 43: 80–97.
   Google Scholar
• Richard-Yegres N, Yegres F. Cladosporium carrionii en vegeta-ción xerófila. Aislamiento en una zona endémica para la cro-momicosis, 1987. Dermatol Venez 1989; 25: 15–18.
   Google Scholar
• Richard-Yegres N, Yegres F, Nishimura K, Makoto M. Viru-lence and pathogenicity of human and environmental isolates of Cladosporium carrionii in new born ddY mice. Mycopathologia 1991; 114: 71–76.
   Google Scholar
• Richard-Yegres N, Yegres F, Zeppenfeldt G. Cromomicosis: endemia rural, laboral y familiar en Venezuela. Rev Iberoam Micol 1992; 9: 38–41.
   Google Scholar
• Zeppenfeldt G, Richard-Yegres N, Yegres F, Hernandez R. Cladosporium carrionii: hongo dimórfico en cactdceas de la zona endémica para la cromomicosis en Venezuela. Rev Iberoam Micol 1994; 11: 61–63.
   Google Scholar
• Carrion AL. Chromoblastomycosis. Ann NY Acad Sci 1950; 50: 1255–1282.
   PubMedGoogle Scholar
• McGinnis MR. Chromoblastomycosis and phaeohyphomyco-sis: new concepts, diagnosis and mycology. J Am Acad Derma-tol 1983; 8: 1–16.
   PubMed Web of Science ®Google Scholar
• Bayles MAH. Chromomycosis: treatment with thiabendazole. Arch Dermatol 1971; 104: 476–485.
   PubMedGoogle Scholar
• Polak AM. Determination de la synergie entre la 5-flucytosine et l'amphotericin B au moyen de differents modbles in vitro et in vivo. Bull Soc Fr Mycol Med 1974; 3: 175–178.
   Google Scholar
• Bopp C. Therapy of chromoblastomycosis with a new method. Med Cutan Ibero Lat Am 1976; 4: 285–292.
   PubMedGoogle Scholar
• Lubritz RR, Spence JE. Chromoblastomycosis. Cure by cryosurgery. Int J Derm 1978; 17: 830–832.
   PubMedGoogle Scholar
• McBumey El. Chromoblastomycosis treatment with ketocona-zole. Cutis 1982; 30: 746–748.
   PubMedGoogle Scholar
• Restrepo A, Gonzales A, GOIT1W I, Arango M, De Bedout C. Treatment of chromoblastomycosis with itraconazole. Ann NY Acad Sci 1988; 544: 504–516.
   PubMedGoogle Scholar
• Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987; 9 (Suppl. 1): S57–S63.
   Google Scholar
• Queiroz-Telles FF, Purim KS, Fiats JN, et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedro-soi. Int J Dermatol 1992; 31: 805–812.
   Google Scholar
• Bolzinger T, Pradinaud R, Sainte-Marie D, Dupont B, Chwet-zoff E. Traitement de quatre cas de chromomycose a Fonsecaea pedrosoi par l'association 5-fluorocytosine-itraconazole. Nouv Derm 1991; 10: 462–466.
   Google Scholar
• Kullavanijaya P, Rojanavanich V. Successful treatment of chro-moblastomycosis due to Fonsecaea pedrosoi by combination of itraconazole and cryotherapy. Int J Dermatol 1995; 34: 804–807.
   PubMed Web of Science ®Google Scholar
• Bayles MAH. Chromomycosis. Bailliere Clin Trop Med Corn-man Dis 1989; 45–70.
   Google Scholar
• Queiroz-Telles F, Purim KS, Boguszweski CL, Afonso FC, Graf H. Adrenal response to corticotrophin and testosterone during long-term therapy with itraconazole in patients with chromoblastomycosis. J Antimicrob Agents Chemother 1997; 40: 899–902.
   Google Scholar
• Esterre P, Inzan CK, Ramarcel ER, et al. Treatment of chro-momycosis with terbinafme: preliminary results of an open pilot study. Br J Dermatol 1996; 134 (Suppl. 46): 33–36.
   Google Scholar
• Marco F, Pfaller MA, Messer AS, Jones RN. Anti-fungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi. Med Mycol 1998; 36: 433–461.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison of in vitro activities of the new triazole 5CH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2961.
   PubMed Web of Science ®Google Scholar